Letter of Support for intermediate Age-Related Macular Degeneration (AMD) biomarker and novel clinical endpoint development
Letter of Support for intermediate Age-Related Macular Degeneration (AMD) biomarker and novel clinical endpoint development
Letter of Support for intermediate Age-Related Macular Degeneration (AMD) biomarker and novel clinical endpoint development
Notification in preparation for the New fee regulation and new prepayment system for certificates of medicinal products, with implementation from January 2025
Public information on medicine shortages
Guidance for industry on implementing shortage mitigation plans (SMP)
Guidance for industry on implementing shortage prevention plans (SPP)
Medicine shortage communication (MSC) template
Agenda of the CHMP meeting 9-12 December 2024
European Commission/EMA meeting with stakeholders on Translarna (ataluren), Online, from 10 December 2024, 11:00 (CET) to 10 December 2024, 12:00 (CET)
Q&A clinic on post-authorisation procedure management in IRIS, Online, European Medicines Agency, Amsterdam, the Netherlands, from 19 December 2024, 11:00 (CET) to 19 December 2024, 12:00 (CET)
Q&A Clinic on post-authorisation procedure management in IRIS - 19 Dec 2024, Online, European Medicines Agency, Amsterdam, the Netherlands, from 19 December 2024, 11:00 (CET) to 19 December 2024, 12:00 (CET)